Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A Peek at Pfizer's Pipeline
Motley Fool
Saturday, September 8, 2012 - 11:02am
tags:
Pfizer
Ten Most Popular Healthcare Stocks Among Hedge Funds
Motley Fool
Saturday, September 8, 2012 - 11:01am
tags:
Express Scripts, Pfizer, JNJ, Unitedhealth Group, Sanofi, Wellpoint, Merck, Abbott, Aetna, HCA Holdings
Another Setback for Lilly
Yahoo/Zacks
Saturday, September 8, 2012 - 10:59am
tags:
Eli Lilly, Alimta
Which Dominant Drugmaker Is a Better Buy Today?
Motley Fool
Saturday, September 8, 2012 - 10:57am
tags:
Pfizer, JNJ
Does This Pharma Deal Make Sense?
Motley Fool
Saturday, September 8, 2012 - 10:56am
tags:
Jazz Pharmaceuticals
Vivus, Arena: Don't Be Too Late To The Punch Bowl, Buy Other Stocks
Seeking Alpha
Saturday, September 8, 2012 - 10:55am
tags:
Vivus, Arena Pharmaceuticals, Pfizer, Neuralstem, Geron
Celgene Walks the Neutral Path
Yahoo/Zacks
Saturday, September 8, 2012 - 10:52am
tags:
Celgene Corporation
Peregrine Shares SHOOT The Moon, Opexa’s New AGREEMENT
Wall Street Cheat Street
Saturday, September 8, 2012 - 10:51am
tags:
Peregrine Pharmaceuticals, Opexa, bavituximab, non-small cell lung cancer, Neptune Technologies & Bioresources
Healthcare Business Update: Sarepta Shares REBOUND, Glaxo Goes TRADITIONAL Chinese
Wall Street Cheat Street
Saturday, September 8, 2012 - 10:49am
tags:
Sarepta Therapeutics, eteplirsen, Duchenne Muscular Dystrophy, Questcor Pharmaceuticals, Acthar, GSK, Merge Healthcare
BioDelivery Sciences International: Making The Most Of This Small-Cap Opportunity
Seeking Alpha
Saturday, September 8, 2012 - 10:44am
tags:
BioDelivery Sciences
Amgen Inc: Today's Featured Drugs Laggard
The Street
Saturday, September 8, 2012 - 10:43am
tags:
Amgen
Questcor Rises After Strong Shipping Numbers: Los Angeles Mover
Bloomberg
Saturday, September 8, 2012 - 10:41am
tags:
Questcor, Acthar, multiple sclerosis
This New Cancer Drug is Boosting Peregrine Pharmaceuticals 48%!
Wall Street Cheat Street
Saturday, September 8, 2012 - 10:40am
tags:
Peregrine Pharmaceuticals, bavituximab, non-small cell lung cancer
Vivus' 60 Critical Minutes That Could Double Qsymia's Addressable Market
Seeking Alpha
Saturday, September 8, 2012 - 10:38am
tags:
Vivus, Qsymia, weight loss, obesity
Pipeline Progress at CELG, Shares Up
Yahoo/Zacks
Saturday, September 8, 2012 - 10:37am
tags:
PALACE-2, PALACE-3, Celgene, psoriatic arthritis
Roche expects to keep Rituxan monopoly until 2015
Fierce Pharma
Friday, September 7, 2012 - 12:22pm
tags:
Roche, cancer, Rituxan, biosimilars
3rd Circuit pay-for-delay ruling sparks Nexium antitrust suits
Reuters
Friday, September 7, 2012 - 12:16pm
tags:
Nexium, pay-for-delay, AstraZeneca, Merck
Celgene Arthritis Treatment Meets Primary Goals in Study
NASDAQ.com
Friday, September 7, 2012 - 12:14pm
tags:
Celgene, apremilast, psoriatic arthritis
AstraZeneca evaluating Starpharma cancer drugs
LifeScientist.au
Friday, September 7, 2012 - 12:13pm
tags:
cancer, AstraZeneca, Starpharma
KV Pharma Loses Lawsuit Against FDA Over Makena
Pharmalot
Friday, September 7, 2012 - 12:07pm
tags:
KV Pharmaceutical, FDA, Makena, premature birth

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.